Table 1 Socio-demographic and clinical characteristics of the study population in Northwest Ethiopia
Variables | HIV-VL coinfected patients (N = 125) Number (%) | HIV infected patients (N = 465) Number (%) | P-value |
|---|---|---|---|
Age in Years | 0.001 | ||
15–24 | 1 (0.8%) | 22 (4.7%) | |
25–34 | 72 (57.6%) | 177 (38.1%) | |
≥ 35 | 52 (41.6%) | 266 (57.2%) | |
Sex | 0.001 | ||
Male | 121 (96.8%) | 178 (38.3%) | |
Female | 4 (3.2%) | 287 (61.7%) | |
Residence | 0.001 | ||
Urban | 85 (68.0%) | 438 (94.2%) | |
Rural | 40 (32.0%) | 27 (5.8%) | |
Educational Status | 0.001 | ||
Uneducated | 65.6 (65.6%) | 210 (45.2%) | |
Primary cycle | 23 (18.4%) | 92 (19.8%) | |
Secondary and above | 20 (16.0%) | 163 (35.1%) | |
Occupation | 0.001 | ||
Farmer | 38 (30.4%) | 26 (5.6%) | |
Daily Labor | 65 (52.0%) | 74 (15.9%) | |
Employed | 16 (12.8%) | 131 (28.2%) | |
No Job | 1 (0.8%) | 63 (13.5%) | |
Merchant | 2 (1.6%) | 52 (11.2%) | |
Housewives | 3 (2.4%) | 119 (25.6%) | |
Religion | 0.481 | ||
Christian | 112 (89.6%) | 426 (91.6%) | |
Muslim | 13 (10.4%) | 39 (8.4%) | |
Ethnicity | 0.001 | ||
Amhara | 82 (65.6%) | 404 (86.9%) | |
Tigray | 38 (30.4%) | 48 (10.3%) | |
Others | 5 (4.0%) | 13 (2.8%) | |
Marital status | 0.001 | ||
Single | 52 (41.6%) | 68 (14.6%) | |
Married | 40 (32.0%) | 234 (50.3%) | |
Separated | 10 (8.0%) | 44 (9.5%) | |
Divorced | 19 (15.2%) | 64 (13.8%) | |
Widowed | 4 (3.2%) | 55 (11.8%) | |
WHO staging | 0.001 | ||
Stage I | - | 302 (64.9%) | |
Stage II | - | 76 (16.3%) | |
Stage III | - | 78 (16.8%) | |
Stage IV | 125 (100%) | 9 (1.9%) | |
On Antiretroviral therapy | 0.001 | ||
Yes | 64 (51.2%) | 465 (100%) | |
No | 61 (48.8%) | ||
CD4 count (mg/dl) | |||
Median (Range) = 340 (from 30 to 1652) | 0.001 | ||
≤ 100 | 71 (57.7%) | 20 (4.3%) | |
101–200 | 38 (30.9%) | 47 (10.1%) | |
≥ 200 | 14 (11.4%) | 398 (85.6%) | |
Observed Hb level (mg/dl) | |||
Mean (±SD) =12.8 (±2.8) | 0.001 | ||
< 12.8 | 120 (96.8) | 101 (23.1%) | |
≥ 12.8 | 4 (3.2) | 336 (76.9%) | |
Spleen size (cm) | |||
< 15 | 109 (94.8%) | NA | |
≥ 15 | 6 (5.2%) | NA |